Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Upadacitinib effectively treats severe alopecia areata and is safe.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Apremilast showed mixed results for treating severe alopecia areata.

Topical tofacitinib is effective and safe for treating alopecia areata.

SM04755 may be an effective topical treatment for psoriasis.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.